Clinical Trial Update: The Benefit of Add On DLBS1033 for Ischemic Stroke Patient [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for DLBS1033 as add-on therapy in ischemic stroke across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• DLBS1033 (DLBS1033)

Snippet

Sponsor: Duta Wacana Christian University | Conditions: Ischemic Stroke | Phase 2, Phase 3 | Status: UNKNOWN